NAB2 and neoplasm: SFTs are characterized by the NAB2-STAT6 oncogenic fusion, which is pathognomonic for this tumor type, and this fusion is believed to drive the overexpression of vascular endothelial growth factor (VEGF), contributing to the highly vascular nature of SFTs [11].